These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35557546)

  • 21. Long-term preservation of cardiac structure and function after adeno-associated virus serotype 9-mediated microdystrophin gene transfer in mdx mice.
    Schinkel S; Bauer R; Bekeredjian R; Stucka R; Rutschow D; Lochmüller H; Kleinschmidt JA; Katus HA; Müller OJ
    Hum Gene Ther; 2012 Jun; 23(6):566-75. PubMed ID: 22248393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of neuromuscular synapse function abnormalities in multiple Duchenne muscular dystrophy mouse models.
    van der Pijl EM; van Putten M; Niks EH; Verschuuren JJ; Aartsma-Rus A; Plomp JJ
    Eur J Neurosci; 2016 Jun; 43(12):1623-35. PubMed ID: 27037492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Second-generation compound for the modulation of utrophin in the therapy of DMD.
    Guiraud S; Squire SE; Edwards B; Chen H; Burns DT; Shah N; Babbs A; Davies SG; Wynne GM; Russell AJ; Elsey D; Wilson FX; Tinsley JM; Davies KE
    Hum Mol Genet; 2015 Aug; 24(15):4212-24. PubMed ID: 25935002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low dystrophin levels increase survival and improve muscle pathology and function in dystrophin/utrophin double-knockout mice.
    van Putten M; Hulsker M; Young C; Nadarajah VD; Heemskerk H; van der Weerd L; 't Hoen PA; van Ommen GJ; Aartsma-Rus AM
    FASEB J; 2013 Jun; 27(6):2484-95. PubMed ID: 23460734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome Editing-Mediated Utrophin Upregulation in Duchenne Muscular Dystrophy Stem Cells.
    Sengupta K; Mishra MK; Loro E; Spencer MJ; Pyle AD; Khurana TS
    Mol Ther Nucleic Acids; 2020 Dec; 22():500-509. PubMed ID: 33230452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modified mRNA-Mediated
    Song MH; Yoo J; Kwon DA; Chepurko E; Cho S; Fargnoli A; Hajjar RJ; Park WJ; Zangi L; Jeong D
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of skeletal muscle pathology and motor function of dystrophin and utrophin deficient mouse strains.
    van Putten M; Kumar D; Hulsker M; Hoogaars WM; Plomp JJ; van Opstal A; van Iterson M; Admiraal P; van Ommen GJ; 't Hoen PA; Aartsma-Rus A
    Neuromuscul Disord; 2012 May; 22(5):406-17. PubMed ID: 22284942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of gene expression differences between utrophin/dystrophin-deficient vs mdx skeletal muscles reveals a specific upregulation of slow muscle genes in limb muscles.
    Baker PE; Kearney JA; Gong B; Merriam AP; Kuhn DE; Porter JD; Rafael-Fortney JA
    Neurogenetics; 2006 May; 7(2):81-91. PubMed ID: 16525850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lifelong quercetin enrichment and cardioprotection in Mdx/Utrn+/- mice.
    Ballmann C; Denney TS; Beyers RJ; Quindry T; Romero M; Amin R; Selsby JT; Quindry JC
    Am J Physiol Heart Circ Physiol; 2017 Jan; 312(1):H128-H140. PubMed ID: 27836895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of nuclear factor κB inhibition on serotype 9 adeno-associated viral (AAV9) minidystrophin gene transfer to the mdx mouse.
    Reay DP; Niizawa GA; Watchko JF; Daood M; Reay JC; Raggi E; Clemens PR
    Mol Med; 2012 May; 18(1):466-76. PubMed ID: 22231732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current Translational Research and Murine Models For Duchenne Muscular Dystrophy.
    Rodrigues M; Echigoya Y; Fukada SI; Yokota T
    J Neuromuscul Dis; 2016 Mar; 3(1):29-48. PubMed ID: 27854202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic Exon Skipping Through a CRISPR-Guided Cytidine Deaminase Rescues Dystrophic Cardiomyopathy in Vivo.
    Li J; Wang K; Zhang Y; Qi T; Yuan J; Zhang L; Qiu H; Wang J; Yang HT; Dai Y; Song Y; Chang X
    Circulation; 2021 Nov; 144(22):1760-1776. PubMed ID: 34698513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiomyopathy in the dystrophin/utrophin-deficient mouse model of severe muscular dystrophy is characterized by dysregulation of matrix metalloproteinases.
    Delfín DA; Zang KE; Schill KE; Patel NT; Janssen PM; Raman SV; Rafael-Fortney JA
    Neuromuscul Disord; 2012 Nov; 22(11):1006-14. PubMed ID: 22749475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac dysfunction and pathology in the dystrophin and utrophin-deficient mouse during development of dilated cardiomyopathy.
    Chun JL; O'Brien R; Berry SE
    Neuromuscul Disord; 2012 Apr; 22(4):368-79. PubMed ID: 22266080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utrophin Compensates dystrophin Loss during Mouse Spermatogenesis.
    Chen HC; Chin YF; Lundy DJ; Liang CT; Chi YH; Kuo P; Hsieh PCH
    Sci Rep; 2017 Aug; 7(1):7372. PubMed ID: 28785010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Celecoxib treatment improves muscle function in mdx mice and increases utrophin A expression.
    Péladeau C; Adam NJ; Jasmin BJ
    FASEB J; 2018 Sep; 32(9):5090-5103. PubMed ID: 29723037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Arginine metabolism by macrophages promotes cardiac and muscle fibrosis in mdx muscular dystrophy.
    Wehling-Henricks M; Jordan MC; Gotoh T; Grody WW; Roos KP; Tidball JG
    PLoS One; 2010 May; 5(5):e10763. PubMed ID: 20505827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphodiesterase 4 inhibitor and phosphodiesterase 5 inhibitor combination therapy has antifibrotic and anti-inflammatory effects in mdx mice with Duchenne muscular dystrophy.
    Nio Y; Tanaka M; Hirozane Y; Muraki Y; Okawara M; Hazama M; Matsuo T
    FASEB J; 2017 Dec; 31(12):5307-5320. PubMed ID: 28798156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment with the anti-IL-6 receptor antibody attenuates muscular dystrophy via promoting skeletal muscle regeneration in dystrophin-/utrophin-deficient mice.
    Wada E; Tanihata J; Iwamura A; Takeda S; Hayashi YK; Matsuda R
    Skelet Muscle; 2017 Oct; 7(1):23. PubMed ID: 29078808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.